Litcius/Paper detail

Erratum to: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

Unknown authors

2023European Heart Journal48 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineOncologyHematologyGynecologic oncologyClinical OncologyMedical physicsCancerChemotherapy-induced cardiotoxicity and mitigationLung Cancer Diagnosis and TreatmentCardiac tumors and thrombi
Erratum to: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) | Litcius